230 filings
Page 4 of 12
6-K
afzy3 9qq2uw
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
iseka6nl626
14 Dec 22
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
4:01pm
6-K
uchcb4oy
7 Dec 22
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
1:08pm
6-K
xc7vvtom289vmjurro
29 Nov 22
Report of Foreign Private Issuer
12:27pm
6-K
b2qq5i wpmupsvkya
16 Nov 22
SciSparc Enters Into Letter of Intent with an E-commerce Company to Establish a Joint Venture to Market and Develop a New Product Line
4:02pm
6-K
e3k5idcp4i149
8 Nov 22
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
7:33am
6-K
tne8f 5v0m
1 Nov 22
Since launch the new product has had approximately 117% ROI
4:00pm
6-K
hv9c1wc
12 Oct 22
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
9:05am
6-K
gmu4muv86 16m2
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
6d8ooepf thmu6qc
16 Sep 22
Report of Foreign Private Issuer
11:03am
6-K
evdk7xj0n45crkxv
25 Aug 22
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment
6:54am
6-K
1sogs5 3h
19 Aug 22
Scisparc Announces the Full Exercise of Pre-Funded Warrants
4:01pm
6-K
jsqqjd rs
16 Aug 22
SciSparc Signs a Non-Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal
6:30am
6-K
zu7w7xy
12 Aug 22
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
4:05pm
6-K
d2pnli0z75 93w93
11 Aug 22
Current Report
4:05pm
6-K
kmmxk
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
6-K
hfsf6u pix6eggae
4 Aug 22
Report of Foreign Private Issuer
4:00pm
6-K
o6irin2ek5c7tn
2 Aug 22
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
4:00pm
6-K
ay15pzrec r6hj
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
6mjolu8w5 3k
7 Jul 22
Report of Foreign Private Issuer
7:49am